Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: 5 | History Defined

2 Top Medical Stocks to Buy and Hold for the Long Term

While the stock market has been under pressure this year, medical stocks have remained resilient due to the inelastic demand for their offerings. Moreover, the demand for medical goods and services is rising amid increasing health awareness and chronic diseases. Given the solid prospects of the industry, fundamentally sound medical…

StockNews.com

3 Stock Plays to Make Before the End of the Year

The Fed indicated a slowdown in its rate hike pace ahead, boosting investors' optimism. Moreover, the economy is showing resilience in the face of macro headwinds. As December is known to be a strong month for the stock market, investors could load up on fundamentally solid stocks, Microsoft (MSFT), Bristol-Myers…

StockNews.com

Is It Too Late to Get in on the Upward Move in This Medical Stock?

Despite economic uncertainties, leading pharma company Bristol-Myers Squibb (BMY) beat street estimates in the fiscal third quarter with solid financials. However, given the current market turmoil, is it too late to get on the upward move in this stock? Continue reading to find out.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Stocks You Won't Regret Buying in December 2022

The Fed Chairman recently indicated a slower pace of rate increases. However, many analysts still believe the economy will face a mild recession next year. Therefore, it could be wise to invest in quality stocks with solid growth prospects, such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Lifeway Foods (LWAY).…

StockNews.com

The 2 Best Stocks to Buy Right Now and the 2 Worst

Consumer confidence dropped month-over-month in November. However, it remains well above the mark, indicating a healthy economy. We think investors’ quality stocks, UnitedHealth Group (UNH) and Bristol-Myers Squibb (BMY), which have solid dividend-paying records, could help navigate the uncertainties. However, fundamentally weak Peloton Interactive (PTON) and Mullen Automotive (MULN) might…

StockNews.com

2 Stocks to Buy if You Want Passive Income in 2023

The Fed is likely to slow down its aggressive monetary policy as analysts believe the economy is finally losing momentum and inflation should decline in the next year. Therefore, investors should consider adding fundamentally sound stocks Bristol-Myers (BMY) and ARC Document (ARC) to their portfolios to ensure a stable passive…

StockNews.com

3 Stocks to Buy This Month if You Haven’t Already

Although the stock market has seen a decline in inflation for October, it is far from the Fed’s target, and rate hikes might continue. However, the anticipation of a strong stock market rebound in 2023 is rising. So, we think it could be wise to load up on fundamentally sound…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

1 Stock to Buy Now That Could Make You Rich in 2023

Biopharmaceutical major Bristol-Myers Squibb Company (BMY) beat the consensus earnings and revenue estimates in the third quarter. Given its strong product pipeline, strategic acquisitions, discounted valuation, high profitability, strong financials, and attractive dividends, investors could buy the stock now. Read more….

StockNews.com

4 Stocks That Could Fetch You High Returns in 2023

Despite continued interest rate hikes by the Fed, analysts believe the U.S. economy is showing resilience. Moreover, inflation is expected to decline significantly next year. Therefore, investing in fundamentally sound stocks Bristol-Myers Squibb (BMY), Lockheed Martin (LMT), HCA Healthcare (HCA), and Murphy USA (MUSA) could help you fetch higher returns…

StockNews.com

2 Strong Health Care Stocks to Add to Your Portfolio Now

The global healthcare industry is showing robust growth prospects with the growing adoption of advanced technologies, rising health awareness, and increasing chronic diseases. Amid rising spending on medicines, fundamentally strong healthcare stocks AbbVie (ABBV) and Bristol-Myers Squibb (BMY) might be ideal additions to your portfolio now. Read on.

StockNews.com

3 Stocks You Shouldn’t Even Think About Selling

As the Fed approved its fourth supersized rate hike early this month, consumer sentiment is slightly worse for the month and the near future. Moreover, the IMF issued a gloomier outlook for the global economy. Therefore, fundamentally solid stocks Bristol-Myers Squibb (BMY), Cigna Corporation (CI), and J.Jill (JILL) could be…

StockNews.com

1 Stock to Buy Today and Thank Yourself Later For

Global biopharmaceutical company Bristol-Myers Squibb (BMY) reported solid third-quarter financials and is well-positioned to witness immense growth in the upcoming quarters, driven by continued progress in its diverse product pipeline. Moreover, the stock is trading above its 50-day and 200-day moving averages, indicating an uptrend. Thus, we think it could…

StockNews.com

2 Pharma Stocks You'll Want to Pay Attention to This Fall

Although the stock market has been under pressure this year due to macroeconomic headwinds, the pharmaceutical industry continues to garner investor attention as it enjoys inelastic demand for its products regardless of economic conditions. Thus, fundamentally-sound pharma stocks Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) could be worth your attention…

StockNews.com

2 A-Rated Stocks to Buy Before It’s Too Late

With the Fed set to launch another supersized rate hike later this week to tame the stubborn inflation, the risk of a recession is only growing. Therefore, we think investors should consider buying fundamentally strong stocks Bristol-Myers Squibb Company (BMY) and TravelCenters of America (TA), which are A-rated in our…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

This Is What Whales Are Betting On Bristol-Myers Squibb

A whale with a lot of money to spend has taken a noticeably bullish stance on Bristol-Myers Squibb. Looking at options history for Bristol-Myers Squibb (NYSE:BMY) we detected 17 strange trades.

StockNews.com

Ready to Make Passive Income? Consider Buying This Health Care Stock

Leading biopharmaceutical company Bristol-Myers Squibb (BMY) reported solid financials in the last quarter. Its diversified product portfolio and inelastic demand for such products brighten its near-term prospects. Moreover, the company’s strong financials put it in a great position to pay dividends increasingly. Hence, it could be an ideal pick for…

StockNews.com

2 Medical Stocks Ready for a Bull Run in Q4

Medical sector tends to be relatively recession-proof due to the inelastic demand for its products and services. And given the solid prospects of the industry, investors could consider buying fundamentally sound medical stocks Johnson & Johnson (JNJ) and Bristol-Myers (BMY), which look poised for a bull run in Q4. Read…

StockNews.com

3 Stocks Delivering Strong Results in 2022 to Buy Now

The central bank might deliver another big rate hike next month to tame the persistently high inflation. However, the corporate earnings season has been gearing up investors’ sentiments. We believe fundamentally sound stocks Bristol-Myers Squibb (BMY), Energy Transfer (ET), and Kroger (KR), which have consistently reported strong financials this year,…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

4 Stocks to Help You Beat the Market

The recent hotter-than-expected jobs data suggests that the Federal Reserve is on track to implement another massive rate hike in its November meeting. While recession remains a strong possibility, the stock market has already begun testing its depths. Hence, it would be wise to invest in fundamentally strong stocks Bristol-Myers…

StockNews.com

2 Stocks to Buy Right Now if You're 50 or Older

With investors fretting about the fate of the global economy amid aggressive interest rate increases, the stock market seems stuck in a vicious loop of volatility. Hence, fundamentally strong stocks with a track record of increasing dividend payouts, Bristol-Myers Squibb (BMY) and CVS Health (CVS), could be considered safe investments…

StockNews.com

The Best Value Stock to Buy for the Long Term

Biopharmaceutical company Bristol-Myers Squibb (BMY) has reported sound financials and possesses a solid upside potential. Given its promising fundamentals, this value stock might be an ideal long-term addition to your portfolio. Keep reading….

StockNews.com

1 Stock Living up to Its Name This Year

Biopharmaceutical company Bristol Myers Squibb (BMY) reported stable revenue growth for the second quarter thanks to outstanding clinical and operational performance. Furthermore, despite generating significant momentum over the past few months, the stock is trading at a discounted valuation. So, we think it may be prudent to scoop its shares…

StockNews.com

3 "Strong Buy" Stocks to Scoop up This Week

High inflation and surging interest rates have heightened fears of a global recession. Amid this uncertain macroeconomic environment, it could be wise to scoop up fundamentally strong stocks Bristol-Myers Squibb (BMY), Centene (CNC), and Ryerson Holding (RYI) for solid long-term returns. These stocks have a Strong Buy rating in our…

StockNews.com

3 Stocks That’ll Help You Score Big No Matter What Happens Next

The Fed launched another 75-basis-point rate hike this week and signaled it would keep increasing rates until inflation is under control. The consecutive rate hikes are raising recession concerns. We think fundamentally solid stocks Bristol-Myers (BMY), AT&T (T), and Gilead Sciences (GILD), which have the potential to deliver steady returns…

StockNews.com

4 Stocks to Buy With Market-Beating Potential

The stock market has been under pressure amid the high inflation and the Fed’s hawkish tilt. The Fed launched another 75 basis-point rate hike on Wednesday and indicated that it would keep increasing rates to bring down inflation to the target level. Thus, we think fundamentally solid stocks AbbVie (ABBV),…

1 … 4 5 6 7

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.